Research programme: phosphatase inhibitors - Incyte
Alternative Names: INCB 012659; MX 7014; MX 7091; MX 7102Latest Information Update: 19 Sep 2006
At a glance
- Originator Incyte Corporation
- Class Small molecules
- Mechanism of Action Apoptosis stimulants; CDC25 phosphatase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Diabetes mellitus; Obesity
Most Recent Events
- 19 Sep 2006 Discontinued - Preclinical for Cancer in USA (unspecified route)
- 19 Sep 2006 Discontinued - Preclinical for Diabetes mellitus in USA (unspecified route)
- 19 Sep 2006 Discontinued - Preclinical for Obesity in USA (unspecified route)